Live stream: Frontiers of liver disease: Managing the impact of advanced liver disease

David Patch was appointed as consultant to the Royal Free in 2019. His interests are portal hypertension and the management of splanchnic vein thrombosis. The Royal Free team has developed a thrombolysis pathway for patients with acute portal vein thrombosis, and this has become particularly relevant in the COVID vaccine era. He is married with three grown up children  and a dog called Norman

Professor Shahid A Khan is Professor of Practice (Hepatology) at Imperial College London and an NHS Consultant Hepatologist at Imperial College Healthcare NHS Trust. He has lectured on liver disease nationally and internationally at Hepatology and Gastroenterology conferences, including state of the art and invited presentations. He is the lead author on the National guidelines for biliary cancer and is co-author on both the International and European guidelines. He has published extensively in the medical literature, including original research articles, reviews and book chapters. Professor Khan is currently Chair of Cholangiocarcinoma UK and serves on the NRCI HPB Cancer National Sub-group Committee and the Advisory Boards of the International Liver Cancer Association and the AMMF Cholangiocarcinoma UK Charity. Professor Khan enjoys a large teaching role, at both undergraduate and postgraduate level and is an accredited UK Royal College of Physicians Educator and. He has supervised several PhD/MD studies in liver disease and is also Director of Admissions and Inclusivity for Imperial College Medical School, as well as previously serving as Director of the Gastroenterology & Hepatology BSc degree programme at Imperial College London and Director of Clinical Studies at St Mary’s Hospital Campus. In light of his educational achievements, he has been selected as a Senior Fellow of the UK’s Higher Education Academy and has won Teaching awards at Imperial College London. He is a member of the British Medical Association, the Association of Physicians of GB and Ireland, the British Association for the Study of the Liver, the British Society of Gastroenterology, the European Association for the Study of the Liver and the International Liver Cancer Association, where he has served as the Chair of a Special Interest Group on biliary cancer.